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ABSTRACT
BACKGROUND: Norepinephrine (NE) is a key neurotransmitter that func-
tionally activates adrenoreceptors expressed in sympathetic neurons. Functional
ucadrenoreceptors are also expressed in dorsal root ganglion (DRG) primary sensory
neurons and regulate neurogenic inflammation and nociceptive responses. Galanin is
involved in inflammation and nociception. It has been suggested that galanin receptor
(GalR) 1 and GalR3 activation induces analgesia at the level of the spinal cord, while
activation of GalR2 has a pronociceptive role in the periphery. Whether activation or
inhibition of u-adrenoreceptors influences galanin expression remains unknown.
OBJECTIVE: The aim of the present study was to investigate whether the
u-adrenoreceptor agonist NE, the u 1-adrenoreceptor antagonist prazosin, and the
u 2-adrenoreceptor antagonist yohimbine affect galanin expression in primary cultured
DRG neurons.
METHODS: DRG was dissected from 240 embryonic 15-day-old Wistar rats,
cultured as dissociated cells for 2 days, and then exposed to NE (l0-4 mol/L) for
another 4 days. In the NE + prazosin group and the NE + yohimbine group, DRG
neurons were pretreated with prazosin (l0-6 mol/L) and yohimbine (l0-5 mol/L) ,
respectively, 10 minutes prior to the NE challenge. The neurons cultured continu-
ously in media served as the controls. All of the cultured samples were processed
to detect galanin mRNA and galanin peptide expression by reverse transcriptase-
polymerase chain reaction and Western blot, respectively. Five samples were tested for
each procedure.
RESULTS: Forty samples were prepared for this study and included in the analy-
sis. After 4 days of incubation, mean (SD) galanin mRNA/13-actin mRNA concentration
ratio was significantly increased with NE compared with controls (0.3349 [0.0413}
vs 0.2411 [0.0519}; P < 0.05). Pretreatment with prazosin seemed to block the effects
ofNE (0.2522 [0.0496}; P < 0.05 vs NE), while yohimbine did not appear to signifi-
cantly alter the effects of NE on elevation of galanin mRNA/13-actin mRNA concen-
tration (0.3154 [0.0239}; P < 0.05 vs controls). Mter 4 days of incubation, galanin/13-actin
concentration ratio was significantly higher with NE compared with controls (0.4406
[0.0655} vs 0.2295 [0.0794}; P < 0.0l). Pretreatment with prazosin appeared to in-
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hibit NE-induced galanin peptide expression (0.3156 [0.0942}; P < 0.05 vs NE),
while yohimbine did not appear to alter the effects of NE on elevation of galanin
peptide concentration (0.3700 [0.0533}; P < 0.05 vs controls).
CONCLUSIONS: In this small in vitro study, NE, likely due to action on
u 1-adrenoreceptors but not u 2-adrenoreceptors, was associated with an increase in
galanin mRNA concentration and galanin peptide expression in these DRG neurons.
These findings might be relevant to noradrenergic pain modulation. (Curr Ther Res
Clin Exp. 2009;70:19-28) © 2009 Excerpta Medica Inc.
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INTRODUCTION
The noradrenergic system is subject to plastic changes that influence its antinocicep-
tive efficacy after injury or inflammation. Norepinephrine (NE) is a key neurotrans-
mitter released by sympathetic postganglionic nerve fibers and is crucial in noradren-
ergic pain modulation. 1 NE functionally activates adrenoreceptors expressed in
sympathetic neurons in a variety of physiologic and pathophysiologic conditions.
Functional u 1-adrenoreceptors are expressed in primary sensory neurons and regulate
neurogenic inflammation and nociceptive responses.2-4 The ucadrenoreceptors have
been found to mediate depolarization in cultured rat dorsal root ganglion (DRG)
neurons5; u 2-adrenoreceptors are also expressed in DRG neurons.
6-S In a study of
transgenic mice lacking functional U 2A-adrenoreceptors, the u 2-adrenoreceptor
antagonist was associated with attenuated nerve injury-induced heat hyperalgesia,
suggesting that it might facilitate the mediation of NE-induced pain.9 In other stud-
ies, u-adrenoreceptor expression in DRG neurons changed after peripheral nerve injury
or inflammationJ,s,10 In 1 study,7 u 2A-adrenoceptor mRNA increased to 45% in all
DRG neuron profiles after unilateral peripheral nerve injury. In another study,S excit-
atory u 2-adrenoreceptors on peripheral nociceptors and their DRG cell bodies were
observed after nerve injury. In the last study,10 an increase in the mRNAs for U 1B-,
U 2A-, and u 2D-adrenoreceptors was found with the ipsilateral DRG after sciatic nerve
injury. The u-adrenoreceptors have a key role in mediating the regulatory effects of
NE on pain. 1 The expression of different subtypes of u-adrenoreceptors increased
after nerve injury.6,11 These adrenoreceptors that are functionally active may vary with
the presence of nerve injury, inflammation, or other physiologic or pathophysiologic
conditions.6,s,11
Galanin expression was reported to be regulated by NE in the magnocellular
neurons of supraoptic nuclei in an ex vivo acute model of rat hypothalamic slices .12
Some freshly dissociated and cultured DRG neurons from adjuvant inflamed rats were
found to have a small depolarization in response to NE.l3 Galanin, a 29-amino acid
neuropeptide in most species (a 30-amino acid neuropeptide in humans), is widely
distributed throughout the nervous system, including the DRG neurons, and is in-
volved in the regulation of various functions, including nociception and developmen-
tal and trophic effects. 14- 19 It has been suggested that galanin receptor (GalR) 1
and GalR3 activation induces analgesia at the spinal cord level, while activation of
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GalR2 has a pronociceptive role in the periphery. 16,20,21 Whether activation or inhibi-
tion of u-adrenoreceptors influences galanin expression remains unknown.
In the present study, we investigated whether the u-adrenoreceptor agonist NE,
the u 1-adrenoreceptor antagonist prazosin, and the u 2-adrenoreceptor antagonist yo-
himbine affect galanin expression in primary cultured DRG neurons.
MATERIALS AND METHODS
STUDY DESIGN
Dorsal Root Ganglion Cell Culture Preparations
DRG was dissected from 240 embryonic 15-day-old Wistar rats. The animals were
obtained from the Experimental Animal Center of Shandong University Ginan,
People's Republic of China). Forty samples were prepared for all experiments. Before
establishment in the culture, DRG was digested with 0.25% trypsin (Sigma-Aldrich,
St. Louis, Missouri) in D-Hanks solution at 3rC for 10 minutes and centrifuged for
5 minutes at 1 x 103 rpm. The supernatants were removed and the pellets were
resuspended in Dulbecco's Modified Eagle Medium with F-12 supplement
(DMEM/F-12) media (Grand Island Biological Company [GIBCO}, Invitrogen, Carls-
bad, California) and triturated using a sterile modified Pasteur's glass pipette. Cells were fil-
tered using a 130-j11ll filter and counted. Dissociated DRG cells were cultured in flasks
(Costar, Corning Incorporated, Corning, New York) to detect the expression of galanin
mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR) and galanin peptide
by Western blot. The flasks were precoated with poly-L-lysine prior to plating the DRG
cells. DRG cells were plated at a density of 5 x 105 cells/mL in flasks. DRG cells were
then incubated in culture media at 3rC with 5% carbon dioxide for 24 hours and then
maintained in culture media containing cytarabine (5 j.lg/mL) for another 24 hours to in-
hibit growth of nonneuronal cells. They were then cultured in culture media for another
4 days, with the media being changed every 2 days. The composition of the culture media
was DMEM/F-12 (1:1) supplemented with 5% fetal bovine serum, 2% B-27 supplement
(GIBCO), insulin (0.25 j.lg/mL, Sigma-Aldrich), L-glutamine (0.1 mg/mL, Sigma-
Aldrich), penicillin (100 U/mL), and streptomycin (100 j.lg/mL).
EXPOSURE OF DORSAL ROOT GANGLION NEURONS TO NOREPINEPHRINE
DRG cell cultures were prepared as described earlier and allowed to grow for
2 days, after which NE 00-4 mol/L) was added. Cultures were incubated for an ad-
ditional 4 days, with the media being changed every 2 days. The culture media con-
tained NE (10-4 mol/L) during the 4 days of incubation. In the NE + prazosin group
and the NE + yohimbine group, DRG neurons were pretreated with prazosin (10-6 mol/L)
and yohimbine 00-5 mol/L), respectively, 10 minutes before the NE challenge. The
neurons cultured continuously in media served as the controls. Five samples were
tested for each procedure.
MRNA EXTRACTION AND RT-PCR
The galanin mRNA concentration was analyzed using RT-PCR after the 4-day
incubation period in the different agents. The expression of 13-actin was also deter-
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mined as an internal control. Total DRG cell RNA in each flask was isolated using
TRIzol® (Invitrogen) reagent. cDNA synthesis was performed using Moloney murine
leukemia virus RT. The gene-specific primers were synthesized using the published
cDNA sequences for galanin and 13-actin.22 The synthetic oligonucleotide primer
sequences for galanin were 5'-ATG CCA ACA AAG GAG AAG AG-3' (upper primer)
and 5'-AGG TGC AAG AAA CTG AGA AA-3' (lower primer), and for 13-actin they
were 5'-ATC ATG TTT GAG ACC TTC AAC-3' (upper primer) and 5'-CAT CTC
TTG CTC GAA GTC CA-3' (lower primer).
The predicted size of the amplified galanin and 13-actin DNA products were 224
and 317 bp, respectively.
PCR amplification was performed for 35 cycles. The cycle profile included dena-
turation for 45 seconds at 94°C, annealing for 60 seconds at 53°C, and extension for
45 seconds at n°c. PCR was performed within the range that demonstrated a linear
correlation between the amount of cDNA and the yield of PCR products.
The amplified products were analyzed using 1.5% standard agarose gel electropho-
resis and stained with ethidium bromide; they were then visualized using an ultra-
violet transilluminator and photographed. DNA marker DL2000 was used as a
molecular standard. The photographs were scanned and the electrophoresis gel
images were analyzed quantitatively using Image] 1.39u image analysis software
(National Institutes of Health, Bethesda, Maryland). Galanin mRNA concentration
was expressed as the ratio of the gene to 13-actin.
WESTERN BLOT ANALYSIS FOR GALANIN PEPTIDE EXPRESSION
Galanin peptide expression was analyzed using Western blot. After 4 days of treat-
ment with the different agents, fresh cultured DRG neurons were homogenized in
10 mmol/L Tris homogenization buffer (pH 7.4) with protease inhibitors (Sigma-Aldrich).
The samples were centrifuged at 12,000 rpm (4°C) for 20 minutes and the supernatant
was then collected for analysis. After determining the protein concentrations of the
supernatants (bicinchoninic acid method and bovine serum albumin [standard}), 50 j.lg
of protein from each sample was loaded onto the 8% sodium dodecyl sulfate gel, sepa-
rated by electrophoresis, and transferred to polyvinylidene fluoride membrane. The
membranes were blocked in blocking buffer (5% nonfat milk) for 2 hours at room tem-
perature (20°C) and were incubated with goat antirat galanin polyclonal immunoglobu-
lin G (IgG) (1:1000, Santa Cruz Biotechnology [SCB}, Inc., Santa Cruz, California) or
mouse antirat 13-actin monoclonal IgG (1: 1000, SCB, Inc.) overnight at 4°C. After be-
ing washed 3 times for 10 minutes with washing solution, the membranes were incu-
bated with donkey antigoat IgG-horseradish peroxidase (HRP) (1:2000, SCB, Inc.) or
goat antimouse IgG-HRP (1:2000, SCB, Inc.) for 2 hours. After being washed 3 times
for 10 minutes with washing solution, the immunoreactive bands were visualized using
an enhanced chemiluminescent Western blotting detection kit (Pierce Biotechnology, a
division of Thermo Fisher Scientific, Rockford, Illinois) on light-sensitive film. The film
was scanned and the images were analyzed quantitatively using Image] 1.39u image
analysis software. Galanin peptide concentration was expressed as the ratio of the protein
to 13-actin.
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STATISTICAL ANALYSIS
The ratio of galanin mRNA to 13-actin mRNA and the ratio of galanin to 13-actin
protein in each group were compared. One-way analysis of variance (ANOVA) was
used according to the 1 influence factor and test of normality. Data are expressed as
mean (SD). Statistical analyses were performed using SPSS software version 13.0 (SPSS
Inc., Chicago, Illinois) by I-way ANOVA followed by the Student-Newman-Keuls
test for significance to compare the between-group differences. P < 0.05 was consid-
ered statistically significant.
RESULTS
SAMPLE SIZE
Forty samples were prepared for the experiments and were all included m the
analysis.
GALANIN MRNA EXPRESSION
After 4 days of incubation, the galanin mRNA/13-actin mRNA concentration ratio
was found to be significantly increased with NE compared with controls (mean [SD},
0.3349 [0.0413} vs 0.2411 [0.0519}; P < 0.05). Pretreatment with prazosin appeared
to block the effects ofNE (0.2522 [0.0496}; P < 0.05 vs NE), while yohimbine was
not associated with significantly altered effects of NE on the increase in galanin
mRNA/13-actin mRNA ratio (0.3154 [0.0239}; P < 0.05 vs controls) (Figure 1).
GALANIN PEPTIDE EXPRESSION
After 4 days of incubation, the galanin/13-actin concentration ratio was signifi-
cantly increased with NE compared with controls (mean [SD}, 0.4406 [0.0655} vs
0.2295 [0.0794}; P < 0.01). Pretreatment with prazosin appeared to inhibit NE-induced
galanin peptide expression (0.3156 [0.0942}; P < 0.05 vs NE), while yohimbine did
not appear to alter the effects ofNE on elevation of galanin peptide expression (0.3700
[0.0533}; P < 0.05 vs controls) (Figure 2).
DISCUSSION
NE, a key neurotransmitter released by sympathetic postganglionic nerve fibers, is
crucial in noradrenergic pain modulation. 1 The physiologic and pathophysiologic as-
pects of the effects of NE have been extensively studied. 23- 25 Based on a literature
search, reports addressing the changes caused by NE in galanin mRNA and galanin
peptide concentration in cultured DRG neurons have not been identified. In the pres-
ent study, the findings suggest that exposure to NE promoted galanin mRNA and
galanin peptide expression in cultured embryonic DRG neurons and that pretreat-
ment with the u1-adrenoreceptor antagonist prazosin inhibited NE-induced galanin
peptide expression, whereas the u 2-adrenoreceptor antagonist yohimbine did not
affect galanin expression.
Galanin might playa role in the adaptive response of the peripheral nervous
system to injury and may modulate pain transmission. 26 Galanin is normally ex-
pressed at low concentrations in sensory neurons in adult DRG27 and is markedly
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Figure 1. Effects of norepinephrine (NE) on galanin mRNA expression in primary cultured
dorsal root ganglion neurons: (A) graph and (B) reverse transcriptase-
polymerase chain reaction findings (Lane 1: normal control [mean (SO), galanin
mRNA/p-actin mRNA ratio = 0.2411 (0.0519)]; Lane 2: NE [0.3349 (0.0413)];
Lane 3: NE + prazosin [0.2522 (0.0496)]; and Lane 4: NE + yohimbine [0.3154
(0.0239)]). *p < 0.05 versus controls; tp < 0.05 versus NE.
upregulated within DRG neurons after peripheral nerve injury or inflammation in
adults. 15 ,26,28-33 Furthermore, galanin is recognized as one of the markers of DRG
injury.34 DRG neurons in vitro have a phenotype similar to that of DRG neurons
after axotomy (ie, a phenotype distinctly different from normal DRG neurons).35
Both galanin mRNA and galanin peptide were expressed to some extent in primary
cultured DRG neurons in the present study. NE appeared to induce an increase in
the expression of galanin mRNA and the neuropeptide in primary cultured DRG
neurons.
NE activates adrenoreceptors to modulate noradrenergic pain. Both u 1- and
u 2-adrenoreceptors have been identified in DRG neurons. A facilitatory role of pe-
ripheral pain modulation mediated by u1-adrenoreceptors has been found in other
24
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Figure 2. Effects of norephinephrine (NE) on galanin peptide expression in primary cul-
tured dorsal root ganglion neurons: (A) graph and (B) Western blot findings
(Lane 1: normal control [galanin//3-actin = 0.2295 (0.0794)]; Lane 2: NE
[0.4406 (0.0655)]; Lane 3: NE + prazosin [0.3156 (0.0942)]; and Lane 4:
NE + yohimbine [0.3700 (0.0533)]). *P < 0.01 versus control; tp < 0.05 versus
NE; 'l'p < 0.05 versus control.
studies. For example, sympathetic efferents acting on peripheral ucadrenoreceptors
facilitate triggering of a dorsal root reflex in nociceptive nerve fibers, suggesting that
NE acting on peripheral u1-adrenoreceptors predominantly facilitates nociceptors. 36
In addition, a whole cell patch clamp study found that the u1-adrenoreceptor agonist
phenylephrine increased excitability of cultured DRG neurons. s However, evidence
has accumulated that u 2-adrenoreceptors have both a facilitatory and an inhibitory
role in peripheral pain modulation. In a study of chronic inflammation-induced
NE sensitivity, NE-induced hypersensitivity was attenuated by an u 2-adrenoreceptor
antagonist, suggesting that u 2-adrenoreceptors may induce pain in hypersensitivityY
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Perineural administration of an u 2-adrenoreceptor agonist attenuated axotomy-
induced hyperexcitability of DRG neurons, suggesting a pain-inhibitory role of
peripheral u 2-adrenoreceptors.
38 Whether u 2-adrenoreceptors in the periphery
contribute to the aggravation of pain or to the suppression of pain is still a mat-
ter of debate. In the present study, the u1-adrenoreceptor antagonist prazosin
appeared to significantly inhibit NE-induced galanin expression, whereas the
u 2-adrenoreceptor antagonist yohimbine did not appear to have this effect. These
results suggested that u1-adrenoreceptors, but not u 2-adrenoreceptors, are involved
in NE-induced galanin expression. Galanin expression might participate in the
pain facilitatory role of u1-adrenoreceptors, whereas the pain facilitatory or in-
hibitory role of u 2-adrenoreceptors might not be mediated by alterations in gala-. .
mn expresslOn.
NE has little influence on pain in healthy tissue, whereas the noradrenergic sys-
tem is subject to various plastic changes that influence its antinociceptive efficacy
after injury or inflammation. 1 The findings in the present study in cultured embry-
onic DRG neuronal cells cannot be extrapolated to the regulation of galanin via
ucadrenoreceptors after NE treatment in clinical practice. We speculate that NE
might have little influence on galanin expression in normal adult DRG neurons in
vivo, but the influence of NE on galanin expression in injury or inflammatory con-
ditions needs to be further clarified.
LIMITATIONS
This study had some limitations, including the small sample size and the lack of
blinding of the study investigators.
CONCLUSIONS
In this small in vitro study, NE, likely due to activity on u1-adrenoreceptors but not
u 2-adrenoreceptors, was associated with an increase in galanin mRNA concentration
and galanin peptide expression in these DRG neurons. These findings might be rele-
vant to noradrenergic pain modulation.
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